Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Comparative genomics on FGF16 orthologs.

Yuriko Katoh¹, Masaru Katoh

¹M&M Medical BioInformatics, Hongo 113-0033, Japan.

International Journal of Molecular Medicine

|October 8, 2005

Summary

This study details comparative genomics of FGF genes, identifying FGF16 as an evolutionarily conserved target of the WNT/beta-catenin pathway. This finding highlights FGF16, FGF18, and FGF20 as potential pharmacogenomics targets for oncology and regenerative medicine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Antibody-drug conjugates targeting the cadherin, claudin and nectin families of adhesion molecules.

Frontiers in molecular medicine·2025

Same author

Claudin 1, 4, 6 and 18 isoform 2 as targets for the treatment of cancer (Review).

International journal of molecular medicine·2024

Same author

Grand Challenges in Molecular Medicine for Disease Prevention and Treatment Through Cyclical Innovation.

Frontiers in molecular medicine·2024

Same author

Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumours.

Clinical and translational medicine·2024

Same author

FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions.

Nature reviews. Clinical oncology·2024

Same author

Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies.

Scientific reports·2024

Area of Science:

Genomics
Evolutionary Biology
Molecular Biology

Background:

Previous comparative genomics analyses covered multiple FGF genes.
This study focuses on FGF1, FGF2, FGF5, FGF9, FGF12, FGF13, FGF14, FGF16, and FGF21.

Purpose of the Study:

To perform comparative genomics analyses on a specific set of FGF genes.
To further characterize the FGF16 gene and its evolutionary conservation.
To investigate the regulatory mechanisms and pathway involvement of FGF16.

Main Methods:

Comparative genomics analysis of FGF gene orthologs across species (chimpanzee, chicken, zebrafish).
Amino-acid identity comparison between human FGF16 and its orthologs.
Phylogenetic analysis of FGF9 and FGF20 orthologs.
Promoter analysis to identify conserved regulatory elements (TCF/LEF binding site, TATA box).

Main Results:

Identified FGF16 orthologs in chimpanzee, chicken, and zebrafish with high amino-acid identity to human FGF16.
FGF16, FGF9, and FGF20 lack N-terminal signal peptides and share conserved middle and C-terminal regions.
Phylogenetic analysis showed closer relationships between zebrafish fgf9 and fgf20 than with mammalian orthologs.
Conserved TCF/LEF binding sites and TATA boxes in FGF16 promoters indicate regulation by the WNT/beta-catenin pathway.

Conclusions:

FGF16 is an evolutionarily conserved target of the WNT/beta-catenin signaling pathway.
FGF16, FGF18, and FGF20 represent potential pharmacogenomics targets.
These findings have implications for oncology and regenerative medicine.

Related Experiment Videos